UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000059436 |
|---|---|
| Receipt number | R000067976 |
| Scientific Title | Effects of lactotripeptide ingestion on muscle fatigue and recovery after resistance exercise |
| Date of disclosure of the study information | 2025/10/16 |
| Last modified on | 2025/10/16 19:32:07 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effects of lactotripeptide ingestion on muscle fatigue and recovery after resistance exercise
Acronym
Lactotripeptide ingestion and muscle fatigue
Scientific Title
Effects of lactotripeptide ingestion on muscle fatigue and recovery after resistance exercise
Scientific Title:Acronym
Lactotripeptide ingestion and muscle fatigue
Region
| Japan |
Condition
Condition
Muscle fatigue
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To examine the effect of lactotripeptide ingestion on muscle fatigue and recovery after resistance exercise
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Developmental phase
Phase III
Assessment
Primary outcomes
Change of maximal isometric force
Key secondary outcomes
Change of mid-thigh circumference
Change of knee range of motion
Change of muscle soreness
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
YES
Dynamic allocation
YES
Institution consideration
Institution is not considered as adjustment factor.
Blocking
NO
Concealment
Pseudo-randomization
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Ingestion of a test substance containing peptides
Interventions/Control_2
Ingestion of placebo
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 39 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Health young adults aged 18 to 39 years
Key exclusion criteria
Have cardiovascular disease
Smoker
A medical doctor has stopped exercise
Have lactose intolerance or milk allergy
Target sample size
25
Research contact person
Name of lead principal investigator
| 1st name | Seiji |
| Middle name | |
| Last name | Maeda |
Organization
Waseda university
Division name
Faculty of sports science
Zip code
359-1192
Address
2-579-15 Mikajima, Tokorozawa, Saitama, Japan
TEL
04-2947-6958
seiji.maeda@waseda.jp
Public contact
Name of contact person
| 1st name | Tomoko |
| Middle name | |
| Last name | Kaneko |
Organization
Waseda university
Division name
Faculty of sports science
Zip code
359-1192
Address
2-579-15 Mikajima, Tokorozawa, Saitama, Japan
TEL
04-2947-6914
Homepage URL
tomoko.kaneko@aoni.waseda.jp
Sponsor or person
Institute
Waseda University
Institute
Department
Personal name
Funding Source
Organization
Asahi Group Foods, Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Review Committee on Human Research of Waseda University
Address
1-104 Totsukamachi, Shinjuku-ku, Tokyo, 169-8050, Japan
Tel
0352721639
rinri@list.waseda.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 10 | Month | 16 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 07 | Month | 29 | Day |
Date of IRB
Anticipated trial start date
| 2025 | Year | 10 | Month | 20 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 10 | Month | 16 | Day |
Last modified on
| 2025 | Year | 10 | Month | 16 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067976
